Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,827 | 101 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $528.67 | 27 | $0 (2024) |
| BIOTISSUE HOLDINGS INC. | $363.77 | 18 | $0 (2024) |
| Oyster Point Pharma, Inc. | $179.39 | 12 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $169.40 | 11 | $0 (2024) |
| Alcon Vision LLC | $156.13 | 7 | $0 (2023) |
| Bausch & Lomb Americas Inc. | $145.40 | 9 | $0 (2024) |
| Tarsus Pharmaceuticals, Inc. | $89.66 | 5 | $0 (2024) |
| Sun Pharmaceutical Industries Inc. | $69.57 | 4 | $0 (2023) |
| Dompe US, Inc. | $46.83 | 3 | $0 (2024) |
| ANI Pharmaceuticals, Inc. | $31.41 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $502.43 | 31 | ABBVIE INC. ($156.38) |
| 2023 | $961.70 | 55 | BIOTISSUE HOLDINGS, INC. ($303.22) |
| 2022 | $363.13 | 15 | ABBVIE INC. ($121.48) |
All Payment Transactions
101 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: Dry eyes | ||||||
| 11/15/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 10/30/2024 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $15.93 | General |
| Category: SOLUTION/ DROPS | ||||||
| 10/24/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 10/09/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: EYE CARE | ||||||
| 09/04/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: IMMUNOLOGY | ||||||
| 08/30/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 07/24/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: EYE CARE | ||||||
| 07/10/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: Ophthalmology | ||||||
| 07/10/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $13.85 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 07/01/2024 | Bausch & Lomb Americas Inc. | enVista MX60 IOL (Device) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: Ophthalmology | ||||||
| 07/01/2024 | Bausch & Lomb Americas Inc. | enVista MX60 IOL (Device) | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: Ophthalmology | ||||||
| 06/20/2024 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: SOLUTION/ DROPS | ||||||
| 05/24/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: EYE CARE | ||||||
| 05/24/2024 | Bausch & Lomb Americas Inc. | enVista MX60 IOL (Device) | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: Ophthalmology | ||||||
| 05/12/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | In-kind items and services | $17.12 | General |
| 05/08/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: IMMUNOLOGY | ||||||
| 05/02/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 05/02/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $9.56 | General |
| Category: EYE CARE | ||||||
| 04/16/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Dry eyes | ||||||
| 04/15/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | In-kind items and services | $22.16 | General |
| 03/18/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | In-kind items and services | $21.27 | General |
| 03/12/2024 | Bausch & Lomb Americas Inc. | enVista MX60 IOL (Device) | Food and Beverage | In-kind items and services | $15.93 | General |
| Category: Ophthalmology | ||||||
| 03/07/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $4.32 | General |
| Category: EYE CARE | ||||||
| 02/27/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: EYE CARE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 406 | 505 | $121,350 | $29,726 |
| 2022 | 4 | 136 | 159 | $44,550 | $12,159 |
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 94 | 141 | $35,250 | $10,525 | 29.9% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 50 | 50 | $15,000 | $5,793 | 38.6% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 36 | 36 | $10,800 | $4,070 | 37.7% |
| 92250 | Photography of the retina | Office | 2023 | 101 | 105 | $31,500 | $3,347 | 10.6% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 19 | 28 | $5,600 | $1,476 | 26.4% |
| 83861 | Microfluid analysis of tears | Office | 2023 | 23 | 50 | $2,500 | $1,102 | 44.1% |
| 92133 | Imaging of optic nerve | Office | 2023 | 23 | 31 | $6,200 | $923.80 | 14.9% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2023 | 19 | 22 | $5,500 | $778.75 | 14.2% |
| 92002 | New patient problem focused exam of visual system | Office | 2023 | 12 | 12 | $3,000 | $768.90 | 25.6% |
| 92134 | Imaging of retina | Office | 2023 | 17 | 18 | $3,600 | $647.93 | 18.0% |
| 92020 | Exam of the internal drainage system of eye | Office | 2023 | 12 | 12 | $2,400 | $294.12 | 12.3% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 45 | 63 | $15,750 | $4,953 | 31.4% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 29 | 29 | $8,700 | $3,766 | 43.3% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 16 | 17 | $5,100 | $1,790 | 35.1% |
| 92250 | Photography of the retina | Office | 2022 | 46 | 50 | $15,000 | $1,651 | 11.0% |
About Asma Saud
Asma Saud is a Ophthalmology healthcare provider based in Dover, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/08/2017. The National Provider Identifier (NPI) number assigned to this provider is 1407389257.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Asma Saud has received a total of $1,827 in payments from pharmaceutical and medical device companies, with $502.43 received in 2024. These payments were reported across 101 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($1,827).
As a Medicare-enrolled provider, Saud has provided services to 542 Medicare beneficiaries, totaling 664 services with total Medicare billing of $41,885. Data is available for 2 years (2022–2023), covering 15 distinct procedure/service records.
Practice Information
- Specialty Ophthalmology
- Location Dover, NJ
- Active Since 04/08/2017
- Last Updated 11/01/2023
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1407389257
Products in Payments
- DURYSTA (Drug) $409.00
- PROKERA (Device) $303.22
- TYRVAYA (Drug) $179.39
- ACTHAR (Biological) $169.40
- LUMIGAN (Drug) $103.40
- XDEMVY (Drug) $89.66
- enVista MX60 IOL (Device) $81.26
- ARGOS (Device) $69.64
- Cequa (Drug) $69.57
- ILUX (Device) $48.71
- OXERVATE (Drug) $46.83
- VYZULTA (Drug) $32.37
- MIEBO (Drug) $31.77
- PURIFIED CORTROPHIN GEL (Drug) $31.41
- Centurion (Device) $23.29
- Syfovre (Drug) $18.72
- ALPHAGAN P (Drug) $16.27
- rocklatan (Drug) $14.49
- TEARLAB OSMOLARITY SYSTEM (Device) $14.45
- VABYSMO (Drug) $13.86
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Dover
Dr. Eric Mann, Md, MD
Ophthalmology — Payments: $596,543
Dr. David Creech, Md, MD
Ophthalmology — Payments: $28,228
David Lu, Md, MD
Ophthalmology — Payments: $4,797
Dr. Timothy Doyle, D.o, D.O
Ophthalmology — Payments: $3,787
Dr. Thomas Perkowski, D.o, D.O
Ophthalmology — Payments: $195.48
Dr. Andrew Wherley, Md, MD
Ophthalmology — Payments: $176.39